THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Avandia maker ordered to halt recruiting for trials

Site in Haverhill one of 17 affected

Related

By Christopher Rowland
Globe Staff / July 22, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

WASHINGTON — The Food and Drug Administration yesterday ordered the maker of the diabetes drug Avandia to stop enrolling new patients in a controversial clinical trial of the widely marketed medicine, saying it needs time to study new evidence of the drug’s risks. (Full article: 745 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass

Health search

Find the latest news on:
Or search:
 

@GlobeHealth on Twitter

    waiting for twitterWaiting for twitter.com to feed in the latest...